Identification of Risk Factors for the Development of Diabetic Retinopathy Among Palestinian Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study
- PMID: 38874277
- PMCID: PMC11177287
- DOI: 10.1002/edm2.494
Identification of Risk Factors for the Development of Diabetic Retinopathy Among Palestinian Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study
Abstract
Introduction: Although risk factors linked to diabetic retinopathy (DR) among patients with Type 2 diabetes mellitus (T2DM) have been extensively studied globally, the specific determinants of these factors in relation to DR in Palestine are presently not well understood.
Methods: This retrospective cross-sectional study included patients who underwent DR screening with a fundus camera (VersaCam a). The study included patients aged ≥18 with T2DM, excluding those with other types of diabetes or a history of malignancies. Univariable and multivariable logistic regressions were used to identify factors associated with DR.
Results: A total of 1163 patients with T2DM were included in this study. Of these, 211 (18.1%) patients were classified in the DR group, 761 (65.4%) in the no DR group and 191 (16.4%) were ungradable. Among the included patients, 434 (37.3%) were male. A secondary level of education or higher and a BMI ≥30 kg/m2, compared with <25 kg/m2, were independently and inversely associated with DR, with odds ratios (ORs) of 0.46 (p < 0.001) and 0.58 (p = 0.046), respectively. A 5-year increase in the duration of T2DM correlated with 45% higher odds of having DR (p < 0.001). Patients with DR were more likely to have HbA1c >7%, be physically inactive and use insulin, with ORs of 1.63 (p = 0.02), 2.05 (p < 0.001) and 1.53 (p = 0.03), respectively. Age, gender, occupational status, hypertension and hyperlipidaemia were not independent predictors of DR (p < 0.05).
Conclusion: Longer duration of T2DM, HbA1c >7%, physical inactivity and insulin use were all independently associated with the presence of DR. Furthermore, a secondary or higher educational level and obesity demonstrated independent and inverse associations with the development of DR.
Keywords: Palestine; Type 2 diabetes mellitus; diabetic retinopathy.
© 2024 The Author(s). Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
[Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].Zhonghua Yan Ke Za Zhi. 2013 Jun;49(6):500-6. Zhonghua Yan Ke Za Zhi. 2013. PMID: 24119962 Chinese.
-
Prevalence, Awareness, and Risk Factors of Diabetic Retinopathy among Adults with Known Type 2 Diabetes Mellitus in an Urban Community in China.Ophthalmic Epidemiol. 2017 Jun;24(3):188-194. doi: 10.1080/09286586.2016.1264612. Epub 2017 Feb 25. Ophthalmic Epidemiol. 2017. PMID: 28276757
-
Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark.Acta Ophthalmol. 2017 Dec;95(8):778-786. doi: 10.1111/aos.13449. Epub 2017 Apr 26. Acta Ophthalmol. 2017. PMID: 28444837
-
Analysis of factors related to diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a cross-sectional study.BMJ Open. 2020 Feb 10;10(2):e032095. doi: 10.1136/bmjopen-2019-032095. BMJ Open. 2020. PMID: 32047012 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
Cited by
-
Integration of Immunometabolic Composite Indices and Machine Learning for Diabetic Retinopathy Risk Stratification: Insights from NHANES 2011 - 2020.Ophthalmol Sci. 2025 Jun 16;5(6):100854. doi: 10.1016/j.xops.2025.100854. eCollection 2025 Nov-Dec. Ophthalmol Sci. 2025. PMID: 40778361 Free PMC article.
References
-
- Forbes J. M. and Cooper M. E., “Mechanisms of Diabetic Complications,” Physiological Reviews 93, no. 1 (2013): 137–188. - PubMed
-
- Ruta L., Magliano D. J., Lemesurier R., Taylor H. R., Zimmet P. Z., and Shaw J. E., “Prevalence of Diabetic Retinopathy in Type 2 Diabetes in Developing and Developed Countries,” Diabetic Medicine 30, no. 4 (2013): 387–398. - PubMed
-
- Teo Z. L., Tham Y. C., Yu M., et al., “Global Prevalence of Diabetic Retinopathy and Projection of Burden Through 2045: Systematic Review and Meta‐Analysis,” Ophthalmology 128, no. 11 (2021): 1580–1591. - PubMed
-
- Ting D. S. W., Cheung G. C. M., and Wong T. Y., “Diabetic Retinopathy: Global Prevalence, Major Risk Factors, Screening Practices and Public Health Challenges: A Review,” Clinical & Experimental Ophthalmology 44, no. 4 (2016): 260–277. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical